Does SARS-CoV-2 natural infection immunity better protect against the Delta variant than vaccination?

A new study from Israel suggests immunity gained after recovering from a bout of COVID-19 is more protective against the new Delta variant than vaccine-induced immunity. Natural immunity was estimated to be about 13 times stronger than having two doses of the Pfizer-BioNTech vaccine.

The researchers write:

This study demonstrated that natural immunity confers longer-lasting and stronger protection against infection, symptomatic disease and hospitalization caused by the Delta variant of SARS-CoV-2, compared to the BNT162b2 two-dose vaccine-induced immunity.”

However, vaccines can add an extra boost to protection in people who recovered from COVID-19. Results showed that a single vaccine dose with natural immunity provided greater protection against reinfection than people with natural immunity alone.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

The study “Comparing SARS-CoV-2 natural immunity to vaccine-induced immunity: reinfections versus breakthrough infections” is published on the medRxiv* preprint server.

How they did it

The research team compared the rate of SARS-CoV-2 infection, the severity of disease, hospitalization, and death in over 16s who had either vaccine-induced or natural immunity.

There were three groups in the study: 673,676 individuals who were fully vaccinated with the Pfizer-BioNTech vaccine and with no prior exposure to SARS-CoV-2; 62,883 unvaccinated individuals who recovered from COVID-19; and 42,099 individuals with prior SARS-CoV-2 infection and who had received a single vaccine dose.

The research team followed up with study participants from June 1 to August 14, 2021. The follow-up period occurred when the Delta variant was common in Israel.

Israel had one of the fastest vaccine rollouts globally. Currently, over 13 million doses have been administered in the country. As a result, the findings make up the largest real-world observational study comparing natural to vaccine-induced immunity.

Increased breakthrough infections and hospitalizations in vaccinated individuals

Vaccinated individuals with no prior exposure to SARS-CoV-2 had a 13.06-fold increased risk of becoming infected with the Delta variant. In addition, there was a 27-fold elevated risk for symptomatic COVID-19.

Although the results could suggest waning natural immunity against the Delta variant, those vaccinated are still at a 5.96-fold increased risk for breakthrough infection and at a 7.13-fold increased risk for symptomatic disease compared to those previously infected,” explained the researchers.

Additionally, vaccinated individuals showed a greater risk of requiring hospitalization from a breakthrough infection than unvaccinated individuals with natural immunity.

People with a single vaccine dose and who previously recovered from infection seemed to have more protection against Delta than unvaccinated people with natural immunity.

There were no COVID-19-related deaths observed in all three groups.

More research investigating the long-term protection of natural immunity is still needed. However, the researchers theorize that natural immunity could be providing a larger immune response towards SARS-CoV-2 proteins than the anti-spike protein immune activation offered by the Pfizer-BioNTech vaccine.

Study limitations and points to consider

The study may have underestimated the number of asymptomatic infections because it collected its data from PCR testing. People with asymptomatic infections are less likely to get tested for SARS-CoV-2, suggesting the results apply primarily to symptomatic infections.

The findings also focused on patients who received the Pfizer-BioNTech vaccine in early 2021. Other research from Israel has recently suggested that vaccine-induced antibody levels wane after several months, but booster shots can enhance immune response. How natural immunity compares to vaccine-induced immunity with booster shots remains unknown.

Additionally, the study findings do not translate to vaccines that are not mRNA-based such as AstraZeneca-Oxford and the Johnson & Johnson vaccines.

The study focused mainly on the Delta variant, which has become widespread in many countries, including Israel. Because Delta was most prevalent during the study, the findings cannot evaluate how natural immunity protects against other SARS-CoV-2 variants.

Lastly, the researchers acknowledge that different health behaviors such as adherence to social distancing and wearing masks could not be controlled for in the study and may have affected the risk of becoming infected.

This news article was a review of a preliminary scientific report that had not undergone peer-review at the time of publication. Since its initial publication, the scientific report has now been peer reviewed and accepted for publication in a Scientific Journal. Links to the preliminary and peer-reviewed reports are available in the Sources section at the bottom of this article. View Sources

Journal references:

Article Revisions

  • Feb 22 2023 - The preprint preliminary research paper that this article was based upon was accepted for publication in a peer-reviewed Scientific Journal. This article was edited accordingly to include a link to the final peer-reviewed paper, now shown in the sources section.
Jocelyn Solis-Moreira

Written by

Jocelyn Solis-Moreira

Jocelyn Solis-Moreira graduated with a Bachelor's in Integrative Neuroscience, where she then pursued graduate research looking at the long-term effects of adolescent binge drinking on the brain's neurochemistry in adulthood.

Citations

Please use one of the following formats to cite this article in your essay, paper or report:

  • APA

    Solis-Moreira, Jocelyn. (2023, February 22). Does SARS-CoV-2 natural infection immunity better protect against the Delta variant than vaccination?. News-Medical. Retrieved on October 15, 2024 from https://www.news-medical.net/news/20210830/Does-SARS-CoV-2-natural-infection-immunity-better-protect-against-the-Delta-variant-than-vaccination.aspx.

  • MLA

    Solis-Moreira, Jocelyn. "Does SARS-CoV-2 natural infection immunity better protect against the Delta variant than vaccination?". News-Medical. 15 October 2024. <https://www.news-medical.net/news/20210830/Does-SARS-CoV-2-natural-infection-immunity-better-protect-against-the-Delta-variant-than-vaccination.aspx>.

  • Chicago

    Solis-Moreira, Jocelyn. "Does SARS-CoV-2 natural infection immunity better protect against the Delta variant than vaccination?". News-Medical. https://www.news-medical.net/news/20210830/Does-SARS-CoV-2-natural-infection-immunity-better-protect-against-the-Delta-variant-than-vaccination.aspx. (accessed October 15, 2024).

  • Harvard

    Solis-Moreira, Jocelyn. 2023. Does SARS-CoV-2 natural infection immunity better protect against the Delta variant than vaccination?. News-Medical, viewed 15 October 2024, https://www.news-medical.net/news/20210830/Does-SARS-CoV-2-natural-infection-immunity-better-protect-against-the-Delta-variant-than-vaccination.aspx.

Comments

  1. Steve Bucci Steve Bucci United States says:

    Why wont the CDC or WHO recognize natural immunity post infection ??   I think I have a good idea as to why...

    • Dwight Ott Dwight Ott United States says:

      money?

    • Brian Hu Brian Hu United States says:

      The entire point of the article was to debunk the rumor that natural immunity is more effective after you've already been infected. The article leads with the sentence "A new study from Israel suggests immunity gained after recovering from a bout of COVID-19 is more protective against the new Delta variant than vaccine-induced immunity." And the rest of the article addresses this rumor with an experiment to back it up.

      • Jenni Talbot Jenni Talbot United States says:

        Read your comment again.  Your rumor statement is redundant at best.  You quote the article correctly afterwords, making it clear that the article says natural immunity from prior infection is stronger than vaccine protection against the disease, but that is not what your initial statement says. The "rumor that natural immunity is more effective after you've already been infected."   And they did say that your natural immunity will be stronger after vaccination with first dose, but your immunity is already stronger with prior disease than those with no prior infection but vaccine-induced immunity.

  2. Jake Salazar Jake Salazar Canada says:

    It looks like the author didn't like the conclusions of this study...

  3. Mark Andersen Mark Andersen Philippines says:

    the author states "Natural immunity was estimated to be about 13 times stronger than having two doses of the Pfizer-BioNTech vaccine."

    The choice of the word ESTIMATED is rather poor as it suggests rather poor reliability.

    The researchers used well-established statistical methods and CALCULATED the difference in immunity and found natural immunity to be 13.06 times more effective and the result had a CI of 95% indicating a very high degree of probability that the statement is true.

The opinions expressed here are the views of the writer and do not necessarily reflect the views and opinions of News Medical.
Post a new comment
Post

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.

You might also like...
Mild COVID-19 disrupts brain connectivity and reduces memory function in adolescents and young adults